VECT
VectivBio Holding AG
NASDAQ: VECT · HEALTHCARE · PHARMACEUTICALS
$16.85
+0.00% today
Updated 2026-04-29
Market cap
$1.06B
P/E ratio
—
P/S ratio
21.08x
EPS (TTM)
$-2.10
Dividend yield
—
52W range
$0 – $0
Volume
—
VectivBio Holding AG (VECT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+100.0%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2023-09-30 | $-0.46 | $0.00 | +100.0% | — | — |
| 2023-06-30 | $-0.67 | $0.00 | +100.0% | — | — |
| 2023-03-31 | $-0.70 | $2.12 | +402.9% | $676000.00 | — |
| 2022-12-31 | $-0.65 | $-0.65 | +0.0% | — | — |
| 2022-09-30 | $-0.58 | $-0.84 | -44.1% | — | — |
| 2022-06-30 | $0.22 | $-0.06 | -127.3% | — | — |
| 2022-03-31 | $-0.61 | $-1.76 | -188.5% | — | — |
| 2021-09-30 | $-0.51 | $-0.52 | -2.0% | — | — |
| 2021-06-30 | $-0.49 | $-0.49 | +0.0% | — | — |
| 2021-03-31 | $-0.57 | $-1.24 | -116.6% | — | — |
Frequently asked questions
Has VectivBio Holding AG beaten earnings estimates?
VectivBio Holding AG has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +100.0% over the last 4 quarters.